Q2 2020
Released Jul 28, 2020, after the close
10-Q filed Jul 28, 2020, 28 days after period end · 0001564590-20-033933
Q2 2020 · 10-Q
Revenue—
Net Income-$4.45M-$4.45M N/M vs Q2 2019N/M vs Q1 2020
EPS Diluted-$0.10-$0.10 N/M vs Q2 2019N/M vs Q1 2020
Operating Income-$4,510,366N/M
Operating Cash Flowderived-$2,090,557N/M
Free Cash Flowderived-$2,090,567N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Net Income | -$4.45M | -$3.88M | -$3.14M | -$2.79M |
| EPS Diluted | -$0.10 | -$0.09 | -$0.08 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR